01 1HETERO LABS LIMITED
02 1MSN Laboratories Private Limited
03 1Pfizer Asia Manufacturing Pte Ltd
04 1Pfizer Ireland Pharmaceuticals
01 4Crizotinib
01 2India
02 2U.S.A
NDC Package Code : 68554-0170
Start Marketing Date : 2011-08-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0501
Start Marketing Date : 2023-03-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68724-1020
Start Marketing Date : 2018-05-24
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60715-1551
Start Marketing Date : 2023-10-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Crizotinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Crizotinib, including repackagers and relabelers. The FDA regulates Crizotinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Crizotinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Crizotinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Crizotinib supplier is an individual or a company that provides Crizotinib active pharmaceutical ingredient (API) or Crizotinib finished formulations upon request. The Crizotinib suppliers may include Crizotinib API manufacturers, exporters, distributors and traders.
click here to find a list of Crizotinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Crizotinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Crizotinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Crizotinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Crizotinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Crizotinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Crizotinib suppliers with NDC on PharmaCompass.
We have 3 companies offering Crizotinib
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
